These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2262 related articles for article (PubMed ID: 24524923)

  • 1. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic inflammatory-demyelinating diseases of the central nervous system.
    Cañellas AR; Gols AR; Izquierdo JR; Subirana MT; Gairin XM
    Neuroradiology; 2007 May; 49(5):393-409. PubMed ID: 17333161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
    Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
    Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants of multiple sclerosis.
    Simon JH; Kleinschmidt-DeMasters BK
    Neuroimaging Clin N Am; 2008 Nov; 18(4):703-16, xi. PubMed ID: 19068410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
    Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical inflammatory demyelinating lesions and atypical multiple sclerosis.
    Ayrignac X; Carra-Dallière C; Labauge P
    Rev Neurol (Paris); 2018 Jun; 174(6):408-418. PubMed ID: 29673573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
    Dale RC; Pillai SC
    Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.
    Dale RC; Brilot F; Banwell B
    Curr Opin Neurol; 2009 Jun; 22(3):233-40. PubMed ID: 19434783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
    Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
    Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.
    Idiman E; Ozakbaş S
    Expert Rev Neurother; 2011 Mar; 11(3):451-62. PubMed ID: 21375450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical subtypes of multiple sclerosis and the immuno-pathogeneses].
    Fujihara K
    Nihon Rinsho; 2003 Aug; 61(8):1293-9. PubMed ID: 12962014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
    Gajofatto A; Bongianni M; Zanusso G; Bianchi MR; Turatti M; Benedetti MD; Monaco S
    Acta Neurol Scand; 2013 Nov; 128(5):336-44. PubMed ID: 23550839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
    Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
    Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
    Frederick MC; Cameron MH
    Curr Neurol Neurosci Rep; 2016 Mar; 16(3):26. PubMed ID: 26847090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic criteria of borderline forms of multiple sclerosis].
    Dupel-Pottier C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical inflammatory demyelinating syndromes of the CNS.
    Hardy TA; Reddel SW; Barnett MH; Palace J; Lucchinetti CF; Weinshenker BG
    Lancet Neurol; 2016 Aug; 15(9):967-981. PubMed ID: 27478954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the neuropathology of atypical forms of multiple sclerosis.
    Stadelmann C; Brück W
    Neurol Sci; 2004 Nov; 25 Suppl 4():S319-22. PubMed ID: 15727225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the spectrum of demyelinating disease in Western Australia.
    Wu JS; Zhang MN; Carroll WM; Kermode AG
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1022-6. PubMed ID: 18356258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 114.